Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11261252 Molecules with specificity for CD79 and CD22

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
July 16, 2019
0
Date of Patent
March 1, 2022
0
Patent Application Number
16513002
0
Patent Citations
‌
US Patent 10590197 Antibody molecules which bind CD22
‌
US Patent 10618957 Antibody molecules which bind CD79
‌
US Patent 10618979 Multispecific antibodies
0
‌
US Patent 10774152 Molecules with specificity for CD45 and CD79
‌
US Patent 10829566 Method employing bispecific antibodies
‌
US Patent 10774157 Multispecific antibodies
‌
US Patent 10954312 Method employing bispecific protein complex
‌
US Patent 10358493 Bispecific format suitable for use in high-through-put screening
0
‌
US Patent 10370447 Molecules with specificity for CD79 and CD22
0
Patent Inventor Names
Stephen Edward Rapecki
0
Helene Margaret Finney
0
Kerry Louise Tyson
0
Michael John Wright
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11261252
0
Patent Primary Examiner
‌
Phuong Huynh
0

Find more entities like US Patent 11261252 Molecules with specificity for CD79 and CD22

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.